rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2007-11-26
|
pubmed:abstractText |
The purpose of this study was to determine the effectiveness and vascular response of a pimecrolimus drug eluting stent and a combination (pimecrolimus + paclitaxel) stent as compared with bare metal controls in the porcine coronary model.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1522-1946
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
871-9
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:17932889-Animals,
pubmed-meshheading:17932889-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:17932889-Blood Vessel Prosthesis Implantation,
pubmed-meshheading:17932889-Calcineurin,
pubmed-meshheading:17932889-Cell Proliferation,
pubmed-meshheading:17932889-Coated Materials, Biocompatible,
pubmed-meshheading:17932889-Coronary Angiography,
pubmed-meshheading:17932889-Coronary Restenosis,
pubmed-meshheading:17932889-Coronary Vessels,
pubmed-meshheading:17932889-Disease Models, Animal,
pubmed-meshheading:17932889-Drug Combinations,
pubmed-meshheading:17932889-Follow-Up Studies,
pubmed-meshheading:17932889-Graft Occlusion, Vascular,
pubmed-meshheading:17932889-Immunosuppressive Agents,
pubmed-meshheading:17932889-Paclitaxel,
pubmed-meshheading:17932889-Stents,
pubmed-meshheading:17932889-Swine,
pubmed-meshheading:17932889-Tacrolimus,
pubmed-meshheading:17932889-Treatment Outcome,
pubmed-meshheading:17932889-Tunica Intima
|
pubmed:year |
2007
|
pubmed:articleTitle |
Pimecrolimus and dual pimecrolimus-paclitaxel eluting stents decrease neointimal proliferation in a porcine model.
|
pubmed:affiliation |
Division of Cardiology, Cedars Sinai Medical Center, Los Angeles, California, USA. ryan.berg@cshs.org
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|